Christopher Davis’s Cigna CI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $621M | Buy |
2,253,424
+19,495
| +0.9% | +$5.51M | 2.67% | 15 |
|
|
2026
Q1 | $596M | Buy |
2,233,929
+1,481,077
| +197% | +$410M | 2.74% | 14 |
|
|
2025
Q4 | $207M | Buy |
752,852
+96,534
| +15% | +$27.1M | 0.93% | 28 |
|
|
2025
Q3 | $189M | Buy |
656,318
+429
| +0.1% | +$127K | 0.99% | 28 |
|
|
2025
Q2 | $217M | Sell |
655,889
-777,362
| -54% | -$251M | 1.16% | 26 |
|
|
2025
Q1 | $472M | Buy |
1,433,251
+1,455
| +0.1% | +$438K | 2.72% | 13 |
|
|
2024
Q4 | $395M | Sell |
1,431,796
-8,075
| -0.6% | -$2.57M | 2.3% | 16 |
|
|
2024
Q3 | $499M | Sell |
1,439,871
-6,258
| -0.4% | -$2.15M | 2.8% | 13 |
|
|
2024
Q2 | $478M | Sell |
1,446,129
-7,041
| -0.5% | -$2.43M | 2.78% | 13 |
|
|
2024
Q1 | $528M | Sell |
1,453,170
-200,113
| -12% | -$65.9M | 2.96% | 14 |
|
|
2023
Q4 | $495M | Sell |
1,653,283
-47,188
| -3% | -$13.8M | 2.8% | 12 |
|
|
2023
Q3 | $486M | Sell |
1,700,471
-21,675
| -1% | -$6.18M | 3.05% | 13 |
|
|
2023
Q2 | $483M | Sell |
1,722,146
-15,910
| -0.9% | -$4.14M | 2.94% | 14 |
|
|
2023
Q1 | $444M | Sell |
1,738,056
-102,042
| -6% | -$29.7M | 2.94% | 15 |
|
|
2022
Q4 | $610M | Sell |
1,840,098
-1,254,391
| -41% | -$397M | 4.14% | 8 |
|
|
2022
Q3 | $859M | Sell |
3,094,489
-43,644
| -1% | -$12.3M | 6.11% | 4 |
|
|
2022
Q2 | $827M | Sell |
3,138,133
-223,850
| -7% | -$57.7M | 5.31% | 4 |
|
|
2022
Q1 | $806M | Sell |
3,361,983
-4,934
| -0.1% | -$1.16M | 4.07% | 8 |
|
|
2021
Q4 | $773M | Buy |
3,366,917
+23,957
| +0.7% | +$5.09M | 3.59% | 11 |
|
|
2021
Q3 | $669M | Buy |
3,342,960
+2,178,225
| +187% | +$474M | 3.09% | 15 |
|
|
2021
Q2 | $276M | Buy |
1,164,735
+4,344
| +0.4% | +$1.08M | 1.13% | 24 |
|
|
2021
Q1 | $281M | Buy |
1,160,391
+402,192
| +53% | +$89.6M | 1.23% | 24 |
|
|
2020
Q4 | $158M | Buy |
758,199
+435,956
| +135% | +$85.5M | 0.76% | 26 |
|
|
2020
Q3 | $54.6M | Buy |
322,243
+215
| +0.1% | +$37.8K | 0.3% | 35 |
|
|
2020
Q2 | $60.4M | Buy |
322,028
+5,778
| +2% | +$1.1M | 0.35% | 33 |
|
|
2020
Q1 | $56M | Buy |
316,250
+138,910
| +78% | +$26.9M | 0.38% | 34 |
|
|
2019
Q4 | $36.3M | Sell |
177,340
-9,776
| -5% | -$1.79M | 0.17% | 51 |
|
|
2019
Q3 | $28.4M | Buy |
187,116
+81,082
| +76% | +$13.2M | 0.14% | 54 |
|
|
2019
Q2 | $16.7M | Buy |
106,034
+7,386
| +7% | +$1.16M | 0.08% | 75 |
|
|
2019
Q1 | $15.9M | Buy |
98,648
+204
| +0.2% | +$37.3K | 0.08% | 83 |
|
|
2018
Q4 | $18.7M | Buy |
+98,444
| New | +$20.5M | 0.1% | 65 |
|
Other funds holding CI
Christopher Davis's CI Position: Q2 2026 in Review
Christopher Davis increased its Cigna (CI) stake by 0.87% in Q2 2026, buying an estimated $5.51M and bringing the position to 2,253,424 shares worth $621M. The position accounts for 2.67% of the portfolio, ranked #15.
Christopher Davis first reported a position in CI in Q4 2018 and has held it in 31 quarters since. The position peaked at $859M in Q3 2022. 1,690 funds tracked by Wall St. Rank hold CI as of Q2 2026.
- Christopher Davis held 2,253,424 shares of Cigna worth $621M as of Q2 2026.
- Christopher Davis bought 19,495 Cigna shares in Q2 2026, an estimated $5.51M.
- Cigna made up 2.67% of Christopher Davis's portfolio in Q2 2026, its #15 holding.
- Christopher Davis first reported a position in Cigna in Q4 2018 and has held it in 31 quarters since.
- Christopher Davis's Cigna position peaked at $859M in Q3 2022.
- 1,690 funds tracked by Wall St. Rank held Cigna as of Q2 2026.
Based on Davis Selected Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.